| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/BMC.2878 |
| P698 | PubMed publication ID | 23483550 |
| P2093 | author name string | Madhira Bhawani Shankar | |
| Palanisamy Danabal | |||
| Ramadass Satiesh Kumar | |||
| Shanmugam Gopinath | |||
| P2860 | cites work | Measurement of naproxen in human plasma by chip-based immunoaffinity capillary electrophoresis | Q33247005 |
| Guidelines for prevention of NSAID-related ulcer complications | Q33412100 | ||
| Current developments in LC-MS for pharmaceutical analysis | Q33425317 | ||
| Determination of esomeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometry | Q33436296 | ||
| Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient | Q34141269 | ||
| Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states | Q34227312 | ||
| Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole | Q34320782 | ||
| Determination of Naproxen Using DBS: Evaluation & Pharmacokinetic Comparison of Human Plasma Versus Human Blood DBS | Q42806899 | ||
| Correlation between in vitro and in vivo concentration-effect relationships of naproxen in rats and healthy volunteers | Q43054314 | ||
| Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. | Q52067661 | ||
| An LC–MS/MS procedure for the quantification of naproxen in human plasma: Development, validation, comparison with other methods, and application to a pharmacokinetic study | Q58856234 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | esomeprazole | Q553223 |
| naproxen | Q1215575 | ||
| P304 | page(s) | 894-899 | |
| P577 | publication date | 2013-03-10 | |
| P1433 | published in | Biomedical Chromatography | Q4915104 |
| P1476 | title | Development and validation of a sensitive and high-throughput LC-MS/MS method for the simultaneous determination of esomeprazole and naproxen in human plasma. | |
| P478 | volume | 27 |
| Q53780909 | A Validated High-Throughput Fluorometric Method for Determination of Omeprazole in Quality Control Laboratory via Charge Transfer Sensitized Fluorescence. |
| Q36197834 | Bioanalytical method for the estimation of co-administered esomeprazole, leflunomide and ibuprofen in human plasma and in pharmaceutical dosage forms using micellar liquid chromatography |
| Q49260711 | Development and validation of a high throughput UPLC-MS/MS method for simultaneous quantification of esomeprazole, rabeprazole and levosulpiride in human plasma |
| Q53060258 | Identifying the proton transfer reaction mechanism via a proton-bound dimeric intermediate for esomeprazoles by a kinetic method combined with density functional theory calculations. |
| Q35803449 | Validated HPLC-UV method for determination of naproxen in human plasma with proven selectivity against ibuprofen and paracetamol. |
Search more.